Design and evaluation of novel potent inhibitors of poly(ADP-ribose) polymerase.

被引：0

作者：

Calabrese, CR ^{[1
]}

Curtin, NJ ^{[1
]}

Canan-Koch, SS ^{[1
]}

Batey, MA ^{[1
]}

Thomas, HD ^{[1
]}

Kyle, S ^{[1
]}

Wang, LZ ^{[1
]}

Boritzki, TJ ^{[1
]}

Webber, SE ^{[1
]}

Griffin, RJ ^{[1
]}

Golding, BT ^{[1
]}

Hostomsky, Z ^{[1
]}

Calvert, AH ^{[1
]}

Newell, DR ^{[1
]}

机构：

[1] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

来源：

CLINICAL CANCER RESEARCH | 2000年 / 6卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

150

引用

页码：4496S / 4496S

页数：1

共 50 条

[21] QSAR studies of phthalazinones: novel inhibitors of poly (ADP-ribose) polymerase
Prarthana V. Rewatkar
Ganesh R. Kokil
Mayuresh K. Raut
Medicinal Chemistry Research, 2011, 20 : 877 - 886
[22] Novel modulators of poly(ADP-ribose) polymerase
Szabo, Csaba
Pacher, Pal
Swanson, Raymond A.
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (12) : 626 - 630
[23] The clinical development of inhibitors of poly(ADP-ribose) polymerase
Calvert, H.
Azzariti, A.
ANNALS OF ONCOLOGY, 2011, 22 : i53 - i59
[24] Poly(ADP-ribose) polymerase inhibitors as cancer therapy
Hilton, John F.
Hadfield, Matthew J.
Tran, Minh-Thu
Shapiro, Geoffrey I.
FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 1393 - 1407
[25] Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma
Vormoor, Britta
Curtin, Nicola J.
CURRENT OPINION IN ONCOLOGY, 2014, 26 (04) : 428 - 433
[26] Poly(ADP-ribose) polymerase inhibitors: toxicity and costs
Reactions Weekly, 2020, 1819 (1) : 9 - 9
[27] STRUCTURAL REQUIREMENTS FOR INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE
SESTILI, P
SPADONI, G
BALSAMINI, C
SCOVASSI, I
CATTABENI, F
DURANTI, E
CANTONI, O
HIGGINS, D
THOMSON, C
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (06) : 615 - 622
[28] Comparative Analyses of Poly(ADP-Ribose) Polymerase Inhibitors
Guha, Mausumee
Sobol, Zhanna
Martin, Mathew
Hemkens, Michelle
Sung, Tae
Rubitski, Elizabeth
Spellman, Richard
Finkelstein, Martin
Khan, Nasir
Hu, Wenyue
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2022, 41 (06) : 442 - 454
[29] Poly (ADP-ribose) Polymerase Inhibitors in Cancer Treatment
Mason, Kathryn A.
Raju, Uma
Buchholz, Thomas A.
Wang, Li
Milas, Zvonimir L.
Milas, Luka
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (01): : 90 - 100
[30] New inhibitors of poly(ADP-ribose) polymerase (PARP)
Peukert, S
Schwahn, U
EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (11) : 1531 - 1551

← 1 2 3 4 5 →